🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tiago V. Pereira

FIND

ORCID: 0000-0002-8574-832X

Also affiliated with Universidade Federal de São Carlos, Universidade de São Paulo, University of Oxford, Instituto de Saúde

Physics and AstronomyMaterials ScienceDecision SciencesBiochemistry, Genetics and Molecular BiologyMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.899Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs

Trials(2018)10.1186/s13063-018-2877-z
Top 22%
0.899DataRank
Top 22%23 citations

Benjamin Speich, Florian Naudet, Arnav Agarwal, Francesco Sclafani, Juan Martin-Liberal +9 more

Papers

Driven by 12 papers — median percentile 78. Top paper: “Statistically significant meta-analyses of clinical trials have modest credibility and inflated effects”.

Statistically significant meta-analyses of clinical trials have modest credibility and inflated effects

Journal of Clinical Epidemiology(2011)10.1016/j.jclinepi.2010.12.012
N/A
7.1DataRank · unranked
160 citations

John P. A. Ioannidis, Tiago V. Pereira

Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.24406
N/A
4.3DataRank · unranked
97 citations

Andreas M. Schmitt, Benjamin Speich, Florian Naudet, Arnav Agarwal, Tiago V. Pereira +12 more

Discovery Properties of Genome-wide Association Signals From Cumulatively Combined Data Sets

American Journal of Epidemiology(2009)10.1093/aje/kwp262
N/A
3.4DataRank · unranked
62 citations

Chris C. A. Spencer, Tiago V. Pereira, Nikolaos A. Patsopoulos, Georgia Salanti, John P. A. Ioannidis

Very large treatment effects in randomised trials as an empirical marker to indicate whether subsequent trials are necessary: meta-epidemiological assessment

BMJ(2016)10.1136/bmj.i5432
N/A
1.7DataRank · unranked
45 citations

Grace Kiew, Douglas G. Altman, Mahiben Maruthappu, John P. A. Ioannidis, Peter McCulloch +2 more

The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs

Trials(2018)10.1186/s13063-018-2877-z
Top 22%
0.899DataRank
Top 22%23 citations

Benjamin Speich, Florian Naudet, Arnav Agarwal, Francesco Sclafani, Juan Martin-Liberal +9 more

Empirical Evaluation of Very Large Treatment Effects of Medical Interventions

JAMA(2012)10.1001/jama.2012.13444
N/A
0.835DataRank · unranked
261 citations

Ralph I. Horwitz, John P. A. Ioannidis, Tiago V. Pereira

Critical interpretation of Cochran's Q test depends on power and prior assumptions about heterogeneity

Research Synthesis Methods(2010)10.1002/jrsm.13
N/A
0.718DataRank · unranked
119 citations

Nikolaos A. Patsopoulos, Georgia Salanti, John P. A. Ioannidis, Tiago V. Pereira

Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies

Journal of Clinical Epidemiology(2019)10.1016/j.jclinepi.2019.05.033
N/A
0.477DataRank · unranked
23 citations

Benjamin Speich, Matthias Briel, Francesco Sclafani, Heiner C. Bucher, Arnav Agarwal +5 more

Robustness of reported postacute health outcomes in children with SARS-CoV-2 infection: a systematic review

Archives of Disease in Childhood(2022)10.1136/archdischild-2022-324455
N/A
0.330DataRank · unranked
8 citations

Perrine Janiaud, Stefan Schandelmaier, Tiago V. Pereira, Steven N. Goodman, John P. A. Ioannidis +5 more

Emergence of Large Treatment Effects From Small Trials—Reply

JAMA(2013)10.1001/jama.2012.208831
N/A
0.312DataRank · unranked
7 citations

Tiago V. Pereira, Ralph I. Horwitz, John P. A. Ioannidis

Validity of reported post-acute health outcomes in children with SARS-CoV-2 infection: a systematic review

medRxiv(2022)10.1101/2022.03.18.22272582
N/A
0.165DataRank · unranked
2 citations

Perrine Janiaud, Viktoria Gloy, Stefan Schandelmaier, Tiago V. Pereira, Despina G. Contopoulos‐Ioannidis +5 more

Effectiveness of fludrocortisone and hydrocortisone versus hydrocortisone alone in septic shock with and without pneumonia

Intensive Care Medicine(2024)10.1007/s00134-024-07552-y
N/A
0DataRank · unranked
3 citations

Tiago V. Pereira, Anica C. Law, C. David Mazer, Nicholas A. Bosch, Bijan Teja